Mitochondrial dysfunction is associated with hypertrophic cardiomyopathy in Pompe disease‐specific induced pluripotent stem cell‐derived cardiomyocytes

Mitochondria in Pathological Cardiac Hypertrophy Research and Therapy

(2022) Dan Yang et al.   Frontiers in Cardiovascular Medicine

Generation of two heterozygous GAA mutation-carrying human induced pluripotent stem cell lines (XACHi005-A, XACHi006-A) from parents of an infant with Pompe disease

(2022) Wenjun Huang et al.   Stem Cell Research

Mitochondrial quality control mechanisms as therapeutic targets in doxorubicin-induced cardiotoxicity

(2022) Lin Wu et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Patient-specific iPSC-derived cardiomyocytes reveal abnormal regulation of FGF16 in a familial atrial septal defect

(2021) Lingqun Ye et al.   CARDIOVASCULAR RESEARCH

Altered Cardiac Energetics and Mitochondrial Dysfunction in Hypertrophic Cardiomyopathy

(2021) Sara Ranjbarvaziri et al.   CIRCULATION

Diazoxide Modulates Cardiac Hypertrophy by Targeting H2O2 Generation and Mitochondrial Superoxide Dismutase Activity

(2019) Aline Maria Brito Lucas et al.   Current Molecular Pharmacology

Assessing metabolic profiles in human myoblasts from patients with late-onset Pompe disease

(2019) Peter Meinke et al.   Annals of Translational Medicine

Generation of induced pluripotent stem cells (iPSCs) from an infant with Pompe disease carrying with compound mutations of R608X and E888X in GAA gene

(2019) Yanmin Zhang et al.   Stem Cell Research

A net-shaped multicellular formation facilitates the maturation of hPSC-derived cardiomyocytes through mechanical and electrophysiological stimuli

(2018) Taoyan Liu et al.   Aging-US

Mitochondrial Dysfunction and Neurodegeneration in Lysosomal Storage Disorders

(2017) Nicoletta Plotegher et al.   TRENDS IN MOLECULAR MEDICINE

Mitochondrial Cardiomyopathy Caused by Elevated Reactive Oxygen Species and Impaired Cardiomyocyte Proliferation

(2017) Donghui Zhang et al.   CIRCULATION RESEARCH

Metabolomic Profiling of Pompe Disease-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Reveals That Oxidative Stress Is Associated with Cardiac and Skeletal Muscle Pathology

(2016) Yohei Sato et al.   Stem Cells Translational Medicine

Defects in calcium homeostasis and mitochondria can be reversed in Pompe disease

(2015) Jeong-A Lim et al.   Autophagy

Disease modeling and lentiviral gene transfer in patient-specific induced pluripotent stem cells from late-onset Pompe disease patient

(2015) Yohei Sato et al.   Molecular Therapy-Methods & Clinical Development

Pompe Disease Results in a Golgi-based Glycosylation Deficit in Human Induced Pluripotent Stem Cell-derived Cardiomyocytes

(2014) Kunil K. Raval et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Chemically defined generation of human cardiomyocytes

(2014) Paul W Burridge et al.   NATURE METHODS

Distinct Metabolic Flow Enables Large-Scale Purification of Mouse and Human Pluripotent Stem Cell-Derived Cardiomyocytes

(2012) Shugo Tohyama et al.   Cell Stem Cell

Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification

(2011) Hsiang-Po Huang et al.   HUMAN MOLECULAR GENETICS

Generation of induced pluripotent stem (iPS) cells derived from a murine model of Pompe disease and differentiation of Pompe-iPS cells into skeletal muscle cells

(2011) Shiho Kawagoe et al.   MOLECULAR GENETICS AND METABOLISM

Murine muscle cell models for Pompe disease and their use in studying therapeutic approaches

(2009) Shoichi Takikita et al.   MOLECULAR GENETICS AND METABOLISM

Pompe's disease

(2008) Ans T van der Ploeg et al.   LANCET